Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype Vectors
Open Access
- 1 December 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 2 (6) , 619-623
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Use of Adeno-Associated Virus to Circumvent the Maturation-Dependent Viral Transduction of Muscle FibersHuman Gene Therapy, 2000
- Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous systemProceedings of the National Academy of Sciences, 2000
- Repeat Transduction in the Mouse Lung by Using Adeno-Associated Virus Vectors with Different SerotypesJournal of Virology, 2000
- Persistent expression of canine factor IX in hemophilia B caninesGene Therapy, 1999
- Adeno-Associated Virus-Mediated Gene Transfer of Factor IX for Treatment of Hemophilia B by Gene TherapyThrombosis and Haemostasis, 1999
- Adeno-associated virus expression systems for gene transferCurrent Opinion in Biotechnology, 1998
- Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2Journal of Virology, 1998
- Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particlesJournal of Virology, 1997
- Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virusProceedings of the National Academy of Sciences, 1997
- Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic proteinProceedings of the National Academy of Sciences, 1996